NCT02598791View on ClinicalTrials.gov

GIP/GLP-1 Co-Activity in Subjects With Obesity: Lowering of Food Intake

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 1, 2015

Primary Completion Date

June 20, 2016

Study Completion Date

June 20, 2016

Conditions
ObesityAdiposityType 2 Diabetes
Interventions
OTHER

IIGI+GIP

Glucose-dependent insulinotropic polypeptide (4 pmol/kg/min) during isoglycemia

OTHER

IIGI+GLP-1

glucagon-like peptide-1 (1 pmol/kg/min) during isoglycemia

OTHER

IIGI+NaCl (placebo)

i.v. NaCl during isoglycemia

OTHER

OGTT

50 g oral glucose tolerance test

OTHER

IIGI+GIP+GLP-1

i.v infusion of GIP and GLP-1 (4 + 1 pmol/kg/min) during isoglycemia

Trial Locations (1)

2900

Center for Diabetesresearch, Gentofte hospital, Hellerup

All Listed Sponsors
lead

University Hospital, Gentofte, Copenhagen

OTHER

NCT02598791 - GIP/GLP-1 Co-Activity in Subjects With Obesity: Lowering of Food Intake | Biotech Hunter | Biotech Hunter